NASDAQ:BHST BioHarvest Sciences Q3 2026 Earnings Date & Estimates $1.46 -0.07 (-4.87%) As of 11/4/2026 04:00 PM Eastern This is a fair market value price provided by Massive. Learn more. BioHarvest Sciences is estimated to report Q3 2026 earnings on Thursday, November 12, 2026, before market opens. The conference call is scheduled for 8:00 AM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 12, 2026TimeBefore Market OpensConference Call8:00 AM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from BioHarvest Sciences in Q3 2026BioHarvest Sciences is expected to post earnings of -$0.16 per share on revenue of $9.31 million. In the same quarter a year earlier BioHarvest Sciences reported -$0.14 per share on revenue of $9.07 million. BioHarvest Sciences last reported on August 10, 2026, posting -$0.17 per share and missing the -$0.13 consensus estimate. BioHarvest Sciences has beaten the consensus EPS estimate in 3 of its last 7 quarters.Consensus EstimatesConsensus EPS-$0.16Expected Revenue$9.31 millionPrior-Year EPS-$0.14Prior-Year Revenue$9.07 millionExpected Revenue Growth+2.6%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.17 (Missed by -$0.04)Last Quarter Revenue$8.84 millionEPS Beat Rate3 of last 7 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report BioHarvest Sciences Q3 2026 Earnings FAQ When does BioHarvest Sciences report Q3 2026 earnings? BioHarvest Sciences (NASDAQ:BHST) is estimated to report Q3 2026 earnings on Thursday, November 12, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it. What time is BioHarvest Sciences' Q3 2026 earnings call? BioHarvest Sciences' Q3 2026 earnings conference call is scheduled for Thursday, November 12, 2026 at 8:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for BioHarvest Sciences? Analysts expect BioHarvest Sciences to post earnings of -$0.16 per share for Q3 2026. How much revenue is BioHarvest Sciences expected to report? The consensus revenue estimate for BioHarvest Sciences is $9.31 million for Q3 2026. BioHarvest Sciences Earnings HeadlinesBioHarvest takes second plant-cell asset to commercial readinessOctober 13, 2026 | proactiveinvestors.comBioHarvest says its platform can produce target sweetener in Tate & Lyle programOctober 8, 2026 | proactiveinvestors.comDollar Reset – Are You Prepared?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected. | Porter & Company (Ad)BioHarvest Sciences Launches Share Buyback to Capitalize on Perceived UndervaluationSeptember 30, 2026 | theglobeandmail.comBioHarvest Sciences launches buyback of up to 5% of sharesSeptember 29, 2026 | proactiveinvestors.comAnalysts Offer Insights on Consumer Goods Companies: JM Smucker (SJM) and BioHarvest Sciences (BHST)September 23, 2026 | theglobeandmail.comSee More BioHarvest Sciences Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like BioHarvest Sciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioHarvest Sciences and other key companies, straight to your email. Email Address About BioHarvest SciencesBioHarvest Sciences (NASDAQ:BHST) is a biotechnology company developing health and wellness products through its proprietary Botanical Synthesis technology. The platform is designed to produce plant-based compounds in controlled environments without relying on conventional agricultural cultivation of the whole plant, with the goal of preserving targeted botanical molecules and improving production consistency. The company’s primary commercial product is VINIA, a dietary supplement made from a proprietary red grape cell culture and marketed for its polyphenol content and potential cardiovascular and general wellness benefits. BioHarvest has also described plans to apply its technology to additional nutraceutical, cosmetic and therapeutic products, including research programs involving botanical compounds for oncology and other health applications. BioHarvest Sciences has operations and research activities connected to Israel and North America and markets its products internationally through direct-to-consumer and commercial distribution channels. The company is led by Chief Executive Officer Ilan Sobel, who has overseen the company’s efforts to expand VINIA and advance its Botanical Synthesis platform.View BioHarvest Sciences ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?Advanced Micro Devices' Q3 Results Answer a Big Question, But Another Remains3 Dividend Increases Above 10%, But Which Offers the Most Income?High Voltage Returns: Talen Energy Powers the Data Center RushBloom Energy: The Off-Grid Answer to AI's Power DrainWhy ExxonMobil and Chevron Reminded Investors to Keep it SimpleEnergy Transfer's Earnings Miss May Be Hiding Its Strongest Advantage Upcoming Earnings Enbridge (11/6/2026)Brookfield Asset Management (11/6/2026)Humana (11/6/2026)Moderna (11/6/2026)Occidental Petroleum (11/9/2026)KKR & Co. Inc. (11/9/2026)Barrick Mining (11/9/2026)Constellation Energy (11/9/2026)Petroleo Brasileiro S.A.- Petrobras (11/10/2026)Transdigm Group (11/10/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
